A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ¿ 18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

Administered By

Awarded By

Contributors

Start/End

  • September 6, 2017 - September 4, 2019